136 related articles for article (PubMed ID: 36167927)
21. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
Datta S; Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Roy G; Das S; Das K; Gupta S; Basu K; Basu A; Datta S; Chowdhury A; Banerjee S
PLoS One; 2014; 9(10):e110012. PubMed ID: 25333524
[TBL] [Abstract][Full Text] [Related]
22. Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion.
Wu JF; Chang KC; Ni YH; Hsu HY; Chang MH
J Infect Dis; 2021 Apr; 223(8):1381-1389. PubMed ID: 32860707
[TBL] [Abstract][Full Text] [Related]
23. The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysis.
Wei F; Zheng Q; Li M; Wu M
Medicine (Baltimore); 2017 May; 96(19):e6835. PubMed ID: 28489767
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma.
Siddiqui ZI; Farooqui SR; Azam SA; Afroz M; Wajid S; Parveen S; Kazim SN
J Viral Hepat; 2017 Dec; 24(12):1121-1131. PubMed ID: 28654219
[TBL] [Abstract][Full Text] [Related]
25. Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.
Puche ML; Kay-Valero S; Michelli P; Oropeza MD; Loureiro CL; Devesa M; Dagher L; Pujol FH
Invest Clin; 2016 Mar; 57(1):38-46. PubMed ID: 27382800
[TBL] [Abstract][Full Text] [Related]
26. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
27. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
28. Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.
Nian X; Xu Z; Liu Y; Chen J; Li X; Xu D
Hepatol Int; 2016 Jul; 10(4):606-15. PubMed ID: 26984835
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
Yeh CT; So M; Ng J; Yang HW; Chang ML; Lai MW; Chen TC; Lin CY; Yeh TS; Lee WC
Hepatology; 2010 Dec; 52(6):1922-33. PubMed ID: 20814897
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
Chen YM; Wu SH; Qiu CN; Yu DJ; Wang XJ
Braz J Med Biol Res; 2013 Jul; 46(7):614-22. PubMed ID: 23903686
[TBL] [Abstract][Full Text] [Related]
31. High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.
Peng XM; Huang GM; Li JG; Huang YS; Mei YY; Gao ZL
World J Gastroenterol; 2005 May; 11(20):3131-4. PubMed ID: 15918203
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between mutations of HBV basal core promoter region in HBsAg-positive mothers and intrauterine transmission].
Wu JX; Yang ZQ; Zhang RJ; Li YD; Zhao TJ; Yi LZ; Feng YL; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jun; 41(6):902-907. PubMed ID: 32564557
[No Abstract] [Full Text] [Related]
35. [Associations between hepatitis B virus x gene mutations and hepatocellular carcinoma].
Wang M; Hu Y; Shi W; Wang Q
Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):599-603. PubMed ID: 26447624
[TBL] [Abstract][Full Text] [Related]
36. HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.
Chen Y; Yu D; Zhang W; Qiu C; Xiang G; Dai W; Wu S; Wang X
Iran J Public Health; 2012; 41(11):10-8. PubMed ID: 23304671
[TBL] [Abstract][Full Text] [Related]
37. Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China.
Wang Z; Tanaka Y; Huang Y; Kurbanov F; Chen J; Zeng G; Zhou B; Mizokami M; Hou J
J Clin Microbiol; 2007 May; 45(5):1491-6. PubMed ID: 17376881
[TBL] [Abstract][Full Text] [Related]
38. Effects of mutations in the X gene of hepatitis B virus on the virus replication.
Yu H; Zhu R; Zhu YZ; Chen Q; Zhu HG
Acta Virol; 2012; 56(2):101-10. PubMed ID: 22720699
[TBL] [Abstract][Full Text] [Related]
39. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
[TBL] [Abstract][Full Text] [Related]
40. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
